GLP1R and diabetes mellitus: There were no significant differences in age, duration of diabetes, BMI, HbA1c, concentration of C-peptide, and drug uses (metformin, dipeptidyl peptidase-4 inhibitor, alpha-glucosidase inhibitors, thiazolidinedione, glucagon-like peptide-1 receptor agonists, sulfonylurea, sodium–glucose cotransporter 2 inhibitors, long-acting insulin, premixed insulin, short-acting insulin) between the two groups.